Critical Illness Myopathy

Muhammad Al-Lozi; Alan Pestronk

doi:10.1002/9781444317008.ch117

Critical Illness Myopathy

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Original language	English
Title of host publication	International Neurology
Subtitle of host publication	A Clinical Approach
Publisher	Wiley Blackwell
Pages	447-448
Number of pages	2
ISBN (Print)	9781405157384
DOIs	https://doi.org/10.1002/9781444317008.ch117
State	Published - May 18 2010

Keywords

CIM incidence in patients - depending on definition of syndrome
CIM, developing in patients - in intensive care unit with acute medical illnesses, as asthma, chronic obstructive pulmonary disease, sepsis
CIM, differentiated from central nervous system and neuromuscular disorders
Critical illness myopathy (CIM), weakness with inexcitable membranes and loss of myosin and thick filaments in muscle fibers
Major pathophysiological changes in CIM - selective loss of major contractile protein (myosin) and inexcitability of muscle membrane
Muscle biopsy, confirming diagnosis - in ruling out potentially treatable causes of weakness
Serum creatine kinase (CK) level, high in patients during first 2 weeks

Access to Document

10.1002/9781444317008.ch117

Cite this

@inbook{deab31293e3249bfab6ce90993a907e1,

title = "Critical Illness Myopathy",

keywords = "CIM incidence in patients - depending on definition of syndrome, CIM, developing in patients - in intensive care unit with acute medical illnesses, as asthma, chronic obstructive pulmonary disease, sepsis, CIM, differentiated from central nervous system and neuromuscular disorders, Critical illness myopathy (CIM), weakness with inexcitable membranes and loss of myosin and thick filaments in muscle fibers, Major pathophysiological changes in CIM - selective loss of major contractile protein (myosin) and inexcitability of muscle membrane, Muscle biopsy, confirming diagnosis - in ruling out potentially treatable causes of weakness, Serum creatine kinase (CK) level, high in patients during first 2 weeks",

author = "Muhammad Al-Lozi and Alan Pestronk",

year = "2010",

month = may,

day = "18",

doi = "10.1002/9781444317008.ch117",

language = "English",

isbn = "9781405157384",

pages = "447--448",

booktitle = "International Neurology",

publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - Critical Illness Myopathy

AU - Al-Lozi, Muhammad

AU - Pestronk, Alan

PY - 2010/5/18

Y1 - 2010/5/18

KW - CIM incidence in patients - depending on definition of syndrome

KW - CIM, developing in patients - in intensive care unit with acute medical illnesses, as asthma, chronic obstructive pulmonary disease, sepsis

KW - CIM, differentiated from central nervous system and neuromuscular disorders

KW - Critical illness myopathy (CIM), weakness with inexcitable membranes and loss of myosin and thick filaments in muscle fibers

KW - Major pathophysiological changes in CIM - selective loss of major contractile protein (myosin) and inexcitability of muscle membrane

KW - Muscle biopsy, confirming diagnosis - in ruling out potentially treatable causes of weakness

KW - Serum creatine kinase (CK) level, high in patients during first 2 weeks

UR - http://www.scopus.com/inward/record.url?scp=84885491714&partnerID=8YFLogxK

U2 - 10.1002/9781444317008.ch117

DO - 10.1002/9781444317008.ch117

M3 - Chapter

AN - SCOPUS:84885491714

SN - 9781405157384

SP - 447

EP - 448

BT - International Neurology

PB - Wiley Blackwell

ER -

Critical Illness Myopathy

Keywords

Access to Document

Other files and links

Cite this